No image published for this recall

No image published for this recall

Nuvision Pharmacy Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244 - safety alert

Official notice

5 Feb 2014

Last checked

5 Feb 2014

Critical riskFDA

An official FDA notice concerns Nuvision Pharmacy Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244 - safety alert. An official FDA notice concerns Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244. The notice reports a serious safety risk. Follow the official notice for consumer instructions. Published 2014-02-05. Lots: N10172012. Recall numbers: D-1052-2014. Check the official notice for the complete list. Published 2014-02-05.

What to do now

The source does not provide specific consumer instructions. Follow the official FDA notice for next steps.

Units affected

122

Recall number

D-1052-2014

Official notice

2014-02-05

The hazard

An official FDA notice concerns Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244. The notice reports a serious safety risk. Follow the official notice for consumer instructions. Published 2014-02-05. Lots: N10172012. Recall numbers: D-1052-2014. Check the official notice for the complete list.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

N10172012

Event Ids

64922

Recall Numbers

D-1052-2014

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244

Units affected

122

Risk / hazard

An official FDA notice concerns Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244. The notice reports a serious safety risk. Follow the official notice for consumer instructions. Published 2014-02-05. Lots: N10172012. Recall numbers: D-1052-2014. Check the official notice for the complete list.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

US · United States · TX · Dallas

Affected area 1

US · United States · TX · Dallas

Affected area 2

US · United States

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Nuvision Pharmacy. Contact: NuVision Pharmacy, Inc..

Source & status

Source

Tier

official

Category

HEALTH

App estimate

critical

Recall details

Recall number

D-1052-2014

Event id

64922

Units affected

122

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

US
No image published for this recall

a product listed in the official notice - safety alert

Medium riskFDA22 May 2013

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 5 Feb 2014. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.